A pharmacist's contribution to an ambulatory neurology clinic

Consultant Pharmacist

Volumn 27, Issue 1, 2012, Pages 49-57

  Swain, Lindy D ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Consultant pharmacist; Dementia; Medication review; Neurology; Parkinson's disease

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMANTADINE; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIPARKINSON AGENT; BENZATROPINE; CALCIUM; CARBIDOPA PLUS LEVODOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; DONEPEZIL; GABAPENTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIPRAMINE; LISINOPRIL; MELATONIN; METOCLOPRAMIDE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYBUTYNIN; PARACETAMOL; PAROXETINE; PREGABALIN; PROTON PUMP INHIBITOR; QUETIAPINE; RISPERIDONE; TRIHEXYPHENIDYL; UNINDEXED DRUG; VITAMIN D;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CONSULTATION; DEMENTIA; DRUG THERAPY; FEMALE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NEUROLOGY; NURSE PRACTITIONER; OUTPATIENT CARE; PATIENT ATTITUDE; PATIENT REFERRAL; PATIENT SATISFACTION; PHARMACIST;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PHARMACISTS; PROFESSIONAL ROLE; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION;

EID: 84856803641     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2012.49     Document Type: Article

References (22)

1. Alzheimer's Association. Facts and figures. Available at http://www.alz.org/alzheimers-disease-facts-and-figures.asp. Accessed March 16, 2011.
2. National Parkinson's Foundation. Parkinson's disease overview. Available at http://www.parkinson.org/parkinson-s-disease.aspx. Accessed March 16, 2011.
3. Armor B, Britton M, Dennis V et al. A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract 2010;23:250-64.
4. Weber C, Ernst M, Sezate G et al. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med 2010;170:1634-9.
5. Delaney L, Chambers C, Roldan G et al. A feasibility study to assess the integration of a pharmacist into neurooncology clinic. J Oncol Pharm Pract 2009;15:79-85.
6. Scott M, Hitch B, Ray L et al. Integration of pharmacists into a patient-centered medical home. J Am Pharm Assoc 2011;51:161-6.
7. Skelton J. White paper on expanding the role of pharmacists in caring for individuals with Alzheimer's disease: APhA Foundation Coordinating Council to Improve Collaboration in Supporting Patients with Alzheimer's Disease. J Am Pharm Assoc 2008;48:715-21.
8. Kaldy J. Making memories matter: the pharmacist's role in memory care. Consult Pharm 2010;25:534-43.
9. Simonson W, Hauser R, Schapira A. Role of the pharmacist in the effective management of wearing-off in Parkinson's disease. Ann Pharmacother 2007;41:1842-9. (Pubitemid 350044347)
10. Chen J. The role of the consultant pharmacist in Parkinson's disease. Consult Pharm 2005;20 Suppl B:22-5.
11. Syfrett M. Pharmacist intervention in the pharmaceutical care of persons with Parkinson's disease. Consult Pharm 2001;16: 137-45.
12. Midlov P, Bondesson A, Eriksson T et al. Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson's disease at nursing homes in southern Sweden. Eur J Clin Pharmacol 2002;57:903-10. (Pubitemid 34185562)
13. Wood L, Neumiller J, Setter S et al. Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease. Am J Geriatr Pharmacother 2010;8:294-315.
14. Larson E, Kukull W, Buchner D. et al. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 1987;107:169-73. (Pubitemid 17137848)
15. Agostini J, Han L, Tinetti M. The relationship between number of medications and weight loss or impaired balance in older adults. J Am Geriatr Soc 2004;52:1719-23. (Pubitemid 41709927)
16. Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish prescribed drug register. Drug Saf 2007;30:911-8. (Pubitemid 47481446)
17. Magaziner J, Cadigan D, Fedder D. Medication use and functional decline among community-dwelling older women. J Aging Health 1989;1:470-84. (Pubitemid 20130393)
18. Field T, Gurwitz J, Harrold L et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004;52:1349-54. (Pubitemid 39038210)
19. Gurwitz J, Field T, Harrold L et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-16. (Pubitemid 37430324)
20. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 2010;170: 1648-54.
21. Steinman M, Landefeld C, Rosenthal G et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006;54:1516-23. (Pubitemid 44564145)
22. Vik S, Maxwell C, Hogan D. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004;38:303-12. (Pubitemid 38112246)